Filing Details
- Accession Number:
- 0000950170-24-131170
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-11-26 18:13:10
- Reporting Period:
- 2024-11-22
- Accepted Time:
- 2024-11-26 18:13:10
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1088856 | Corcept Therapeutics Inc | CORT | Pharmaceutical Preparations (2834) | 770487658 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1817838 | Douglas Joseph Lyon | C/O Corcept Therapeutics Incorporated 101 Redwood Shores Parkway Redwood City CA 94065 | See Remarks | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2024-11-22 | 1,411 | $56.72 | 8,494 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Includes 460 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, 507 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, and 1,232 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.